Monovalent rotavirus vaccine effectiveness and long-term impact among children <5 years old in Antananarivo, Madagascar, 2010–2022

Monovalent rotavirus vaccine substantially reduced rotavirus disease burden after introduction (May 2014) in Madagascar. We examined the effectiveness and long-term impact on acute watery diarrhea and rotavirus-related hospitalizations among children 50 % of the genotypes detected post-introduction....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2024-12, Vol.42 (26), p.126321, Article 126321
Hauptverfasser: Raboba, Julia Liliane, Rahajamanana, Vonintsoa Lalaina, Rakotojoelimaria, Haganiaina Elsa, Masembe, Yolande Vuo, Martin, Patricia Rasoamihanta, Weldegebriel, Goitom G., Diallo, Alpha Oumar, Burnett, Eleanor, Tate, Jaqueline E., Parashar, Umesh D., Mwenda, Jason M., Seheri, Mapaseka, Magagula, Nonkululeko, Mphahlele, Jeffrey, Robinson, Annick Lalaina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Monovalent rotavirus vaccine substantially reduced rotavirus disease burden after introduction (May 2014) in Madagascar. We examined the effectiveness and long-term impact on acute watery diarrhea and rotavirus-related hospitalizations among children 50 % of the genotypes detected post-introduction. Rotavirus vaccine has been successfully implemented in Madagascar's routine childhood immunization program and had a large impact on rotavirus disease burden, supporting continued use of rotavirus vaccines in Madagascar.
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2024.126321